- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/092 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain
Patent holdings for IPC class C07D 295/092
Total number of patents in this class: 46
10-year publication summary
|
2
|
2
|
2
|
2
|
6
|
7
|
1
|
1
|
0
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Enzo Therapeutics, Inc. | 29 |
9 |
| Virginia Commonwealth University | 628 |
7 |
| XENIOPRO GmbH | 15 |
4 |
| Cybrexa 1, Inc. | 3 |
2 |
| Janssen Pharmaceutica N.V. | 3395 |
1 |
| Bayer Pharma AG | 1053 |
1 |
| The Board of Trustees of the Leland Stanford Junior University | 6402 |
1 |
| Takeda Pharmaceutical Company Limited | 2714 |
1 |
| Agro-kanesho Co., Ltd. | 48 |
1 |
| Baylor University | 338 |
1 |
| Chanrx Corporation | 5 |
1 |
| Cytomics Systems | 3 |
1 |
| Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. | 58 |
1 |
| Metabolys | 7 |
1 |
| NATCO Pharma Limited | 208 |
1 |
| NHWA Pharma. Corporation | 51 |
1 |
| Northeastern University | 1188 |
1 |
| Pontificia Universidad Catolica de Chile | 295 |
1 |
| Sunovion Pharmaceuticals Inc. | 270 |
1 |
| Nocion Therapeutics, Inc. | 42 |
1 |
| Other owners | 8 |